companydata.dkcompanydata.dk

ASTION PHARMA A/S: Financial statements 2018

CVR: 34224781

Source: annual report 2018, Danish Business Authority

01/01/2018 – 31/12/2018

ASTION PHARMA A/S (CVR 34224781) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -392,051 and a net result of DKK -409,449 compared with DKK -1,543,930 the year before. Equity in the 2018 report amounted to DKK 500,000.

Gross Profit
DKK -392,051
Profit/Loss
DKK -409,449
Equity
DKK 500,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018--392 t.-409 t.500 t.-
2017--48 t.-1.5 mio.7.7 mio.0
2016--187 t.117 t.15.7 mio.0
2015--783 t.-5.8 mio.15.6 mio.-
2014--1.2 mio.-3.4 mio.21.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

Morten Bo Madsen joins ASTION PHARMA A/S as directorSep 1, 2018

As of September 1, 2018, Morten Bo Madsen is registered as director of ASTION PHARMA A/S.

Jan Kruse Hansen joins ASTION PHARMA A/S as directorSep 1, 2018

As of September 1, 2018, Jan Kruse Hansen is registered as director of ASTION PHARMA A/S.

Jens Heimburger steps down as director of ASTION PHARMA A/SAug 31, 2018

As of August 31, 2018, Jens Heimburger has stepped down as director of ASTION PHARMA A/S.

ASTION PHARMA A/S: The 2017 annual report is outMar 10, 2018

ASTION PHARMA A/S has published its annual report for 2017. Gross profit came to DKK -47,792, and the net result was DKK -1,543,930.

Ib Henrik Rønje joins the board of ASTION PHARMA A/SFeb 1, 2018

As of February 1, 2018, Ib Henrik Rønje has joined the board of directors of ASTION PHARMA A/S.

Torben Holger Schultz leaves the board of ASTION PHARMA A/SFeb 1, 2018

As of February 1, 2018, Torben Holger Schultz has left the board of directors of ASTION PHARMA A/S.

About ASTION PHARMA A/S

ASTION PHARMA A/S is a Danish company of the type Aktieselskab based in Vissenbjerg, founded in 2012. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named AP NEWCO A/S. The management consists of Torben Rønje. The board consists of Ib Henrik Rønje (chair), Henrik Grønfeldt-Sørensen and Torben Rønje. The company is owned by KAPITALFORMIDLINGS INSTITUTTET A/S. The company has 0 employees (2017). In 2025, the company reported a gross profit of DKK -18,071 and a net result of DKK -164,736 compared with DKK -246,248 the year before. Equity in the 2025 report amounted to DKK -5,950,429.

Source: annual report 2025, Danish Business Authority